Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.44 (
AGT
)
770
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the present study, we have investigated the analgesic effect of the aqueous extract of the root of Glycine tomentella (
AGT
) using models of acetic acid-induced writhing response and formalin test, the anti-inflammatory effect of
AGT
using model of lambda-carrageenan-induced paw edema. In order to investigate the anti-inflammatory mechanism of
AGT
, we have detected the activities of
glutathione peroxidase
(GPx) and glutathione reductase (GRx) in the liver and the levels of malondialdehyde (MDA) and NO in the edema paw. In the analgesic test,
AGT
(0.5 and 1.0 g/kg) decreased the acetic acid-induced writhing response and the licking time on the late phase in the formalin test. In the anti-inflammatory test,
AGT
(0.5 and 1.0 g/kg) decreased the paw edema at the third, fourth, fifth and sixth hour after lambda-carrageenan administration, and increased the activities of SOD, GPx and GRx in the liver tissue and decreased the MDA level in the edema paw at the third hour after lambda-carrageenan injection. However,
AGT
could not affect the NO level which induced by lambda-carrageenan. These results suggested that
AGT
possessed analgesic and anti-inflammatory effects. The anti-inflammatory mechanism of
AGT
might be related to the decrease in the level of MDA in the edema paw via increasing the activities of SOD, GPx and GRx in the liver.
...
PMID:Analgesic and anti-inflammatory activities of aqueous extract from Glycine tomentella root in mice. 1761 91
The article deals with studying of enzyme activity of first and second lines of anti-oxidant defense in adolescents with arterial hypertension and establishing role of genetic component in realization of mechanism of development of this pathology. The main group included 20 adolescents aged from 13 to 16 years with diagnosis of arterial hypertension stage I (risk). The control group consisted of 20 healthy adolescents of corresponding age. The study was carried out to detect activity of superoxide dismutase [EC 1.15.1.1], catalase [EC 1.11.1.6],
glutathione peroxidase
[EC 1.11.1.9], glucose-6-phosphate dehydrogenase [EC 1.1.1.49]. The concentration of reduced glutathione was established using photoelectrocolorimeter KFK-2MP (Russia). The activity of glutathione reductase [EC 1.8.1.7] was evaluated using spectrophotometer CF-46 (LOMO, Russia). The content of nitrogen oxide was detected using V.A. Metelskaia and N.G. Gumanova technique (2005). The detection of genetically mediated risk of development of arterial hypertension and identification of gene-gene dependencies (ACE,
AGT
, NOS3) was implemented using technique of PCR-RFLP diagnostic ("DNA-technology", Russia). The genetic analysis identified in main group the following gene-candidates: deletion genotype DD for ACE, polymorphism M235T T->C gene
AGT
, version 786 C/C gene NOS3. All of then can be applied in diagnostic of arterial hypertension. In adolescents with arterial hypertension imbalance of molecular mechanisms of anti-oxidant defense was revealed. This condition is manifested by imbalance in functioning of enzymes of first line of anti-oxidant defense and accumulation of H2O2, increasing of activity of
glutathione peroxidase
and depressing of activity of the rest of glutathione depending enzymes. Against this background, decreasing of content of nitrogen oxide results in development of endothelial dysfunction.
...
PMID:[The genetic biochemical markers of arterial hypertension in Adolescents.] 3156 70